CLINICAL_TRIALS
trial_result
· 2021-08-09
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD) [Phase 2]
Summary
Phase 2 trial assessing filgotinib for small bowel Crohn's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Small Bowel Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-08-09